SCHEMBL28696325

SCHEMBL28696325

Fc1ccc(Nc2ncnc3cc(OCCCC4COCCN4)c(OCCCC4COCCN4)cc23)cc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.60
▸ CIT O14578 1/20 0.60
▸ GAK O14976 1/20 0.60
▸ EPHB6 O15197 1/20 0.60
▸ ABCC4 O15439 1/20 0.60
▸ DAPK3 O43293 1/20 0.60
▸ RIPK2 O43353 1/20 0.60
▸ NR1I2 O75469 1/20 0.60
▸ RPS6KA4 O75676 1/20 0.60
▸ STK17B O94768 1/20 0.60
▸ STK10 O94804 1/20 0.60
▸ PRKD3 O94806 1/20 0.60
▸ ABCB11 O95342 1/20 0.60
▸ MAP4K4 O95819 1/20 0.60
▸ CHEK2 O96017 1/20 0.60
▸ ABL1 P00519 1/20 0.60
▸ ERBB2 P04626 1/20 0.60
▸ LCK P06239 1/20 0.60
▸ LYN P07948 1/20 0.60
▸ RET P07949 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4787463 0.87 EGFR (0.70) EGFRCITGAKEPHB6RIPK2
SCHEMBL28696327 0.82 EPHA2 (0.67) EGFRCITGAKEPHB6ABCC4
SCHEMBL29577645 0.80 FBP1 (0.78) EGFRERBB2FLT4KDREPHB4
SCHEMBL29577315 0.80 FBP1 (0.78) EGFRERBB2FLT4KDREPHB4
SCHEMBL4535987 0.80 KDR (0.78) EGFRCITGAKEPHB6ABCC4
SCHEMBL7867197 0.79 FLT1 (0.66) EGFRFLT4KDREPHB4
SCHEMBL15217656 0.79 EGFR (0.90) EGFRERBB2FLT4KDREPHB4
SCHEMBL28387145 0.79 EPHA2 (0.72) EGFRCITGAKEPHB6ABCC4
SCHEMBL29577833 0.78 EGFR (0.92) EGFRCITGAKEPHB6ABCC4
SCHEMBL28713534 0.78 EGFR (0.92) EGFRCITGAKEPHB6ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108069913-B Bis (morpholinylalkoxy) quinazoline derivative and application thereof in anti-tumor aspect 陕西师范大学 2022-03-01 — — CN disclosed
Send feedback